Dysregulated T Cell Activation and Aberrant Cytokine Expression Profile in Systemic Lupus Erythematosus

Table 1

Clinical manifestations and clinical features of SLE patients at the time of the study.

Characteristics	SLE ()
Age (years)
Female : male	44 : 5
Clinical manifestations no. (%)
Malar rash/discoid rash	32 (65.3)
Photosensitivity	16 (32.7)
Oral ulcer	12 (24.5)
Arthritis/arthralgia	38 (77.6)
Autoimmune hemolytic anemia	35 (71.4)
Leukopenia	18 (36.7)
Lymphopenia	34 (69.3)
Immune thrombocytopenia	23 (46.9)
Renal involvement	41 (83.7)
Neurological involvement	6 (12.2)
SLEDAI
Serological features (%)
Anti-dsDNA Abs	32
Serum C3 (g/L)
Serum C4 (g/L)

Abbreviations: SLE: systemic lupus erythematosus; SLEDAI: SLE disease activity index; dsDNA: double-stranded DNA; C3: complement 3; C4: complement 4.